Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Hudson Technologies reported second quarter 2026 revenues of $78.3 million, an 8% increase year-over-year driven by a 12% sales volume growth offset by 6% lower selling prices due to refrigerant market conditions. The company restored operations quickly after a tornado-impacted facility disruption, announced a partnership with Icorium to scale adva…
ThredUp Inc. announced its Q2 2026 results, achieving record quarterly revenue of $90.8 million, up 17% year-over-year, and active buyers increasing 21%. Gross margin improved slightly to 79.9%, and adjusted EBITDA reached $4.8 million. Despite strong quarterly performance, the company lowered its H2 2026 guidance due to economic uncertainty impact…
RxSight, Inc. reported Q2 2026 revenue of $33.7 million, including $6.5 million from its strategic collaboration with Alcon, alongside a 19% decline in product sales reflecting market pressures. The company appointed Aziz Mottiwala as CEO and initiated development of next-generation light adjustable lens technology but withdrew its 2026 financial g…
Cytek Biosciences reported a 6% year-over-year revenue increase to $48.1 million for Q2 2026, driven by strong instrument sales growth in the US and China and expanding recurring revenue from services and reagents. The company launched new products including Cytek Borealis and Aurora Evo with enhanced features. Despite the revenue growth and improv…
ARC Group Securities Acquisition I, a Cayman Islands exempted blank check company, announced the closing of its $105 million IPO with 10.5 million units priced at $10 each. The units began trading on Nasdaq under the ticker FJDIU. Each unit consists of one Class A ordinary share, one redeemable warrant, and one right to receive a fractional share a…
EverCommerce Inc. announced its Q2 2026 financial results with revenue up 2.7% year-over-year to $152 million and net income from continuing operations increasing to $9.7 million. Adjusted EBITDA was slightly lower than the previous year at $44.5 million but exceeded the upper end of guidance. The company repurchased 1.4 million shares and updated …
Nyxoah SA reported robust financial and operating results for Q2 and H1 2026, driven by successful U.S. commercial execution post FDA approval of its lead product, the Genio system for treating obstructive sleep apnea. The company achieved 22% sequential revenue growth in the U.S. for Q2 and secured $110 million in financing to expand its commercia…
Biomea Fusion reported continued progress in its clinical programs targeting diabetes and obesity, including ongoing enrollment in Phase II trials for icovamenib in Type 2 diabetes and promising durability data in Type 1 diabetes. The company also advanced its Phase I trial for the obesity candidate BMF-650 and initiated a research collaboration fo…
Sight Sciences delivered significant growth in Q2 2026 with revenues increasing 20% year-over-year. Interventional Dry Eye revenues surged 704% driven by higher volumes and selling prices. The company achieved strong gross margins, improved cash usage, and decreased operating expenses, leading to a 63% reduction in net loss compared to the prior ye…
Nasdaq has published its trading volume statistics for July 2026 on its Investor Relations website, providing transparency on market activity. The data highlights ongoing market operations through Nasdaq's technology platform which continues to support global financial markets.
ADMA Biologics delivered a strong second quarter in 2026 with total revenue up 2% year-over-year to $124.4 million, powered by a 24% increase in ASCENIV revenues. The company's flagship product, ASCENIV, showed accelerated demand and utilization, while BIVIGAM revenue stabilized after prior declines. GAAP net income grew 11% year-over-year to $37.8…
Vaxcyte reported its Q2 2026 financial results, highlighting progress in its VAX-31 pneumococcal conjugate vaccine Phase 3 program with topline data from the OPUS-1 trial expected by Q4 2026 and additional OPUS-2 and OPUS-3 results in H1 2027. The company is also advancing its early-stage pipeline including VAX-A1 for Group A Streptococcus in Phase…
Crane NXT, Co. (NYSE: CXT) announced robust financial results for Q2 2026, including a 22% year-over-year increase in sales to $493 million and a 13% rise in adjusted earnings per share (EPS) to $1.10. The company raised its full-year adjusted EPS guidance to a range of $4.22 to $4.42, reflecting confidence in ongoing momentum and successful integr…
Barrett Business Services, Inc. (NASDAQ: BBSI) reported Q2 2026 revenues increased 4% to $319.3 million with gross billings rising 3%. Despite revenue growth driven by new client additions and higher billings per employee, net income declined to $12.9 million ($0.52 per diluted share) compared to $18.5 million ($0.70 per diluted share) last year, m…
Great Elm Capital Corp. (GECC) announced its second quarter 2026 financial results, highlighting a 3% quarter-over-quarter NAV increase to $7.95 per share, $0.32 net investment income per share, and $1.9 million of net realized and unrealized gains. The company strengthened its capital structure by retiring expensive debt, extended its revolving cr…
Tenaya Therapeutics announced positive interim Phase 1b/2 clinical trial results for gene therapies TN-201 and TN-401 treating hypertrophic cardiomyopathy (HCM) and arrhythmogenic right ventricular cardiomyopathy (ARVC), respectively. Both treatments showed meaningful clinical improvements and good tolerability. The company is progressing TN-301, a…
Sweetgreen stock climbed 6.4% in afternoon trading to $6.08 as investors accumulated shares ahead of the company’s Q2 2026 earnings, due after the market close on Thursday, August 6, 2026. Analysts expect an EPS loss of $0.10 and about $194 million in revenue for the quarter. With a significant portion of the float sold short and analyst price targ…
Enel's share price is carving higher on steady fundamentals and constructive technicals. With a market cap of $117.6B, a 2.42% yield and a P/E of 24.4, the stock looks positioned to continue a grid-led re-rating. This trade targets further upside while protecting capital on a defined stop.
Yum! Brands stock climbed in afternoon trading after the company reported better-than-expected Q2 results and management signaled that Taco Bell sales are recovering. The rally comes amid an expanding cyclosporiasis outbreak linked to iceberg lettuce served at Taco Bell, a public health issue now spanning 15 states with Michigan reporting over 12,0…
Palantir reported $1.9B in Q2 revenue (93% YoY) and raised FY guidance to roughly $8.15B, signaling that enterprise AI adoption is accelerating beyond government work. The stock is richly valued, but momentum, improving fundamentals, and a still-small commercial AI penetration argue for a targeted long trade over the next 180 trading days with a st…
Ares Management is leading a $2.2 billion direct loan to fund MedImpact Holdings Inc.'s acquisition of Puerto Rico-based Medical Card System, Inc. The debt would carry a premium of at least 8 percentage points above the benchmark rate, be secured as second-lien, and remains subject to ongoing negotiations. Ares Class A shares fell 2.3% on Wednesday…
U.S. authorities have paused avocado export inspections in Mexico’s Michoacan state after a security alert, interrupting USDA verification at authorized packinghouses. The suspension prevents normal processing of fruit destined for the United States and could delay shipments from a region that supplies the bulk of Mexico’s exports to its largest ma…
The U.S. Senate voted 51 to 44 to confirm Erica Schwartz as director of the Centers for Disease Control and Prevention, filling a role that had been occupied by acting leaders for almost a year. Her nomination faced scrutiny over whether she would push back against Health and Human Services Secretary Robert F. Kennedy Jr. on vaccine policy and pers…
Sandisk Corporation’s upcoming earnings release is expected to reverberate through the memory and storage sector. Investors are watching Micron Technology, Western Digital and Seagate closely because Sandisk’s numbers act as a barometer for NAND pricing and storage demand. Pre-market moves already show sharp declines for several names, underscoring…
Freshworks is showing durable multi-product sales strength, positive cash flow, and improving profitability while trading at a reasonable multiple for a software company. We like a risk-defined long trade at current levels ($11.50) targeting a re-rating to $16.00 over a 180 trading-day horizon, with a stop at $9.75.
